☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
VivaVision Biotech
VivaVision Biotech Reports Topline P-II Trial Data of VVN461 for Non-Infectious Anterior Uveitis
April 25, 2025
VivaVision Biotech Reports Topline Results from P-II Study of VVN461 for Post-Operative Inflammation Following Cataract Surgery
December 5, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.